Literature DB >> 9539149

A new family of orphan G protein-coupled receptors predominantly expressed in the brain.

O Valdenaire1, T Giller, V Breu, A Ardati, A Schweizer, J G Richards.   

Abstract

The cloning of a cDNA encoding a G protein-coupled receptor homologous to the endothelin type B receptor, but unable to bind endothelin, was recently reported and termed ET(B)R-LP. We report here the isolation of a human cDNA encoding a receptor that is highly related to ET(B)R-LP and which was therefore termed ET(B)R-LP-2. Comparison of the two amino acid sequences revealed 68% overall homology and 48% identity. As is the case for ET(B)R-LP, the new receptor is strongly expressed in the human central nervous system (e.g. in cerebellar Bergmann glia, cerebral cortex, internal capsule fibers). Membranes of HEK-293 cells stably expressing ET(B)R-LP-2 did not bind endothelin-1, endothelin-2, endothelin-3, bombesin, cholecystokinin-8 or gastrin-releasing peptide.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539149     DOI: 10.1016/s0014-5793(98)00170-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

1.  Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands.

Authors:  Timothy J Gollan; Michael R Green
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  G protein-coupled receptor 37L1 regulates renal sodium transport and blood pressure.

Authors:  Xiaoxu Zheng; Laureano D Asico; Xiaobo Ma; Prasad R Konkalmatt
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-19

3.  GPR37L1 modulates seizure susceptibility: Evidence from mouse studies and analyses of a human GPR37L1 variant.

Authors:  Michelle M Giddens; Jennifer C Wong; Jason P Schroeder; Emily G Farrow; Brilee M Smith; Sharon Owino; Sarah E Soden; Rebecca C Meyer; Carol Saunders; J B LePichon; David Weinshenker; Andrew Escayg; Randy A Hall
Journal:  Neurobiol Dis       Date:  2017-07-06       Impact factor: 5.996

4.  Mice lacking Gpr37 exhibit decreased expression of the myelin-associated glycoprotein MAG and increased susceptibility to demyelination.

Authors:  Brilee M Smith; Michelle M Giddens; Jessica Neil; Sharon Owino; TrangKimberly T Nguyen; Duc Duong; Fengqiao Li; Randy A Hall
Journal:  Neuroscience       Date:  2017-06-20       Impact factor: 3.590

Review 5.  The protective role of prosaposin and its receptors in the nervous system.

Authors:  Rebecca C Meyer; Michelle M Giddens; Brilee M Coleman; Randy A Hall
Journal:  Brain Res       Date:  2014-08-15       Impact factor: 3.252

Review 6.  Hunting for the function of orphan GPCRs - beyond the search for the endogenous ligand.

Authors:  Raise Ahmad; Stefanie Wojciech; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

7.  Localization and functional roles of corticotropin-releasing factor receptor type 2 in the cerebellum.

Authors:  Natalia V Gounko; Albert Gramsbergen; Johannes J L van der Want
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

8.  Primary Cilia in the Murine Cerebellum and in Mutant Models of Medulloblastoma.

Authors:  Chiara Di Pietro; Daniela Marazziti; Gina La Sala; Zeinab Abbaszadeh; Elisabetta Golini; Rafaele Matteoni; Glauco P Tocchini-Valentini
Journal:  Cell Mol Neurobiol       Date:  2016-03-02       Impact factor: 5.046

9.  Precocious cerebellum development and improved motor functions in mice lacking the astrocyte cilium-, patched 1-associated Gpr37l1 receptor.

Authors:  Daniela Marazziti; Chiara Di Pietro; Elisabetta Golini; Silvia Mandillo; Gina La Sala; Rafaele Matteoni; Glauco P Tocchini-Valentini
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-23       Impact factor: 11.205

10.  GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin.

Authors:  Rebecca C Meyer; Michelle M Giddens; Stacy A Schaefer; Randy A Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.